Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...
Morning Overview on MSN
Science says we’re raising 'gifted' kids the wrong way
Across classrooms and kitchen tables, adults still talk about “gifted” children as if brilliance were a fragile heirloom that ...
“I think time is running out,” he said. “We’re not in the 10th inning anymore, we’re in the 13th or 14th.” In December, the ...
The Feast of Christmas celebrates a truth so immense that it redefines human destiny: ‘God’ became one like us – ‘man’! The Mystery of the Word made flesh, is not merely a Theological event but a ...
Omeros Corporation (NASDAQ: OMER) today announced that the U.S. Food and Drug Administration (FDA) has approved YARTEMLEA® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback